20 Hrs
المصدر:
الاقتصادية
Moderna Shares Rise on Skin Cancer Data
Moderna's stock rose by 200%, from $63 to $190, following positive results regarding an effective treatment for skin cancer. This boosted investor confidence and led to a significant surge in the market.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading